Literature DB >> 7837041

Human calcitonin delivery in rats by iontophoresis.

S Thysman1, C Hanchard, V Préat.   

Abstract

In-vitro ionotophoresis (0.33 mA cm-2) of calcitonin (50 micrograms mL-1, pH 4) was performed with the hairless rat skin model. Direct current was as potent as pulse current (2.5 kHz on/off 1/1) iontophoresis in promoting transdermal permeation of calcitonin. Increase in duration of current application from 20 min to 1 h did not increase calcitonin flux. Results suggest that calcitonin can be blocked in the skin pores through which it travels or can accumulate in the skin and be progressively released from the depot. In-vivo experiments showed that transdermal iontophoretic administration of calcitonin induced a hypocalcaemic effect in rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7837041     DOI: 10.1111/j.2042-7158.1994.tb03891.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.

Authors:  P Santi; P Colombo; R Bettini; P L Catellani; A Minutello; N M Volpato
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

3.  Enhanced Skin Delivery of Therapeutic Peptides Using Spicule-Based Topical Delivery Systems.

Authors:  Chi Zhang; Jiwen Duan; Yongxiang Huang; Ming Chen
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.